The aim of the current study was to examine prospectively the relationship between the systemic inflammatory markers CRP, TNF-α, IL-1ß and IL-6 and loss of fat free mass over a 3-year time period, using data from the Bergen COPD Cohort Study in Western Norway. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.